U.S., July 4 -- ClinicalTrials.gov registry received information related to the study (NCT07050524) titled 'Omega-3 Supplementation and Immunotherapy in Gastric Cancer: A Phase II Trial' on June 26.
Brief Summary: The goal of this clinical trial is to learn if Omega-3 fatty acids supplementation can enhance the efficacy of neoadjuvant immunotherapy in patients with locally advanced gastric and gastroesophageal junction adenocarcinoma. The main questions it aims to answer are: does Omega-3 supplementation improve the pathologic complete response (pCR) rate compared to standard neoadjuvant immunotherapy alone, and is there an increase in the major pathological response (MPR) rate with Omega-3 supplementation? Researchers will compare the gro...